Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001454815-15-000004
Filing Date
2015-11-20
Accepted
2015-11-20 17:19:47
Documents
1
Effectiveness Date
2015-11-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7947
  Complete submission text file 0001454815-15-000004.txt   9017
Mailing Address 350 CAMBRIDGE AVENUE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVENUE SUITE 350 PALO ALTO CA 94306 650-272-6138
EIGER BIOPHARMACEUTICALS INC (Filer) CIK: 0001454815 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-251688 | Film No.: 151247537